Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of Empasiprubart in adults with dermatomyositis and myositis; current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Myositis

Drugs mentioned

• Empasiprubart

Snippet

Sponsor: argenx | Conditions: Dermatomyositis, Myositis | Phase 2 | Status: ACTIVE_NOT_RECRUITING